Zobrazeno 1 - 10
of 106
pro vyhledávání: '"C, Granolleras"'
Autor:
C. Prelipcean, Gérard Deshodt, Samir Boubenider, Bachir Zabadani, Eric Picard, C. Granolleras, J. Fourcade, S. Cariou, Bernard Hory, B. Branger, F. Vecina, Pascal Branchereau, Maria Eugenia Noguera, Philippe Rousseau, Pascale Fabbro-Peray, Pierre Ramperez, Pascal Reboul
Publikováno v:
Néphrologie & Thérapeutique. 7:237-241
Arteriovenous fistula (AVF) is still in 2010 the gold standard of vascular(2) access in haemodialysis (HD) patients. Nevertheless it may be difficult to obtain and/or to use AVF in elderly. With this prospective randomised pilot study, we compare two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::256be70c5787f4719ac5ece0c6634c0d
https://doi.org/10.1016/j.nephro.2011.04.001
https://doi.org/10.1016/j.nephro.2011.04.001
Autor:
M. Latour Brinza, B. Branger, F. Vecina, J.P. Balducchi, C. Granolleras, R. Oulès, J. Fourcade
Publikováno v:
La Revue de Médecine Interne. 21:319s-321s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d99cc23a55ac3667a49bf09b8ce57a4e
https://doi.org/10.1016/s0248-8663(00)89257-7
https://doi.org/10.1016/s0248-8663(00)89257-7
Publikováno v:
Blood Purification. 8:268-271
Recombinant human erythropoietin (EPO) has been used for 4 years in end-stage renal disease patients, administered intravenously 3 times a week. A study was undertaken to determine the optimal way of administration comparing 3 times weekly intravenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbef9642f65e9306562e81d996047b0
https://doi.org/10.1159/000169977
https://doi.org/10.1159/000169977